Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common
Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
(a)
Market Information
Our Units began trading on the NYSE on October
9, 2020. Each Unit consists of one Class A ordinary share and one-fourth of one redeemable warrant to purchase one Class A ordinary share.
On November 27, 2020, we announced that holders of the Units may elect to separately trade the Class A ordinary shares and redeemable
warrants included in the Units commencing on November 30, 2020. Any Units not separated continue to trade on the New York Stock Exchange
under the symbol “IPOE.U.” Any underlying Class A ordinary shares and redeemable warrants that were separated trade on the
NYSE under the symbols “IPOE” and “IPOE WS,” respectively.
(b)
Holders
As of March 15, 2021, there was approximately
one holder of record of our Units, approximately one holder of record of our separately traded Class A ordinary share, and approximately
two holders of record of our redeemable warrants.
(c)
Dividends
We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial Business Combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial Business Combination. The payment of any cash dividends subsequent to our initial Business Combination
will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating
and does not anticipate declaring any share dividends in the foreseeable future. In September 2020 and October 2020, we effected share
capitalizations, resulting in an aggregate of 20,125,000 founder shares issued and outstanding, in order to maintain the number of founder
shares at 20% of our issued and outstanding ordinary shares upon the consummation of the Initial Public Offering. Further, if we incur
any indebtedness in connection with our initial Business Combination, our ability to declare dividends may be limited by restrictive covenants
we may agree to in connection therewith.
(d)
Securities Authorized for Issuance Under Equity Compensation Plans
None.
(e)
Performance Graph
The performance graph has been omitted as permitted
under rules applicable to smaller reporting companies.
(f)
Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
On October 14, 2020, we consummated our Initial
Public Offering of 80,500,000 Units, inclusive of 10,500,000 Units sold to the underwriters upon the election to fully exercise their
over-allotment option, at a price of $10.00 per Unit, generating total gross proceeds of $805,000,000. Each Unit consists of one Class
A ordinary share of the Company, par value $0.0001 per share, and one-fourth of one redeemable warrant of the Company. Each whole warrant
entitles the holder thereof to purchase one Class A ordinary share Ordinary Share for $11.50 per share, subject to adjustment. Credit
Suisse acted as the sole book-running manager. The securities sold in the offering were registered under the Securities Act on registration
statements on Form S-1 (Nos. 333-248915 and 333-249396). The registration statements became effective on October 8, 2020.
Simultaneously with the consummation of the Initial
Public Offering, and the exercise of the over-allotment option in full and the sale of the Private Placement Warrants, we consummated
a private placement of 8,000,000 Private Placement Warrants to our Sponsor at a price of $2.00 per Private Placement Warrant, generating
total proceeds of $16,000,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of
the Securities Act.
The Private Placement Warrants are identical to
the warrants sold as part of the Units in the Initial Public Offering except that, so long as they are held by the Sponsor or its permitted
transferees: (1) they will not be redeemable by us (except in certain redemption scenarios when the price per Class A ordinary share equals
or exceeds $10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject
to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of our Business Combination;
(3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A ordinary Shares issuable upon exercise
of these warrants) are entitled to registration rights.
35
Of the gross proceeds received from the Initial
Public Offering and the full exercise of the option to purchase additional Units, $805,000,000 was placed in the Trust Account.
We paid a total of $14,000,000 in underwriting
discounts and commissions and $484,062 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters
agreed to defer $28,175,000 in underwriting discounts and commissions.
For a description of the use of the proceeds generated
in our Initial Public Offering, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
Item 6. Selected Financial Data.
Selected financial data has been omitted as permitted
under rules applicable to smaller reporting companies.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.